Now more than ever, international cooperation is needed to fight back against the pandemic. A protectionist approach to R&D will serve no one’s interests
In exclusive written Q&A with Science|Business, EU commissioner for research, innovation, education and youth vows hundreds of millions for coronavirus R&D but calls on member states to agree on the multiannual budget to avoid delaying critical research.
EU president Charles Michel says there is ‘strong common will’ between G7 countries to deliver coronavirus vaccine, following reports of big-money overture by president Trump to CureVac
Brussels outlines broad cooperation with UK in nuclear research, renewable energy and antimicrobial resistance, and suggests visa waivers for short-term researcher visits
Early stage human trials for vaccine against the virus are ‘days or weeks’ away, but it will take at least 12 – 18 months to complete safety and efficacy tests, and much more money is needed
All universities in Italy, Greece, Denmark, Poland, Ireland and Hungary are closed down, as EU education and research ministers meet online to discuss coordinated response
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.